Manabu Ohyama, Atsushi Shimizu, Kyoko Tanaka, Masayuki Amagai: Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. In: Journal of Dermatological Science. Band58, Nr.2, Mai 2010, S.154–157, doi:10.1016/j.jdermsci.2010.03.009, PMID 20388588.
Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak, Martin Storr, Jakub Fichna: Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. In: Journal of Neurogastroenterology and Motility. Band23, Nr.3, 30. Juli 2017, S.341–348, doi:10.5056/jnm16203, PMID 28551943, PMC 5503283 (freier Volltext).
Anne-Marie Ellegaard, Christian Dehlendorff, Anna C. Vind, Atul Anand, Luise Cederkvist: Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. In: EBioMedicine. Band9, Juli 2016, S.130–139, doi:10.1016/j.ebiom.2016.06.013, PMID 27333030, PMC 4972561 (freier Volltext).
J Sastre: Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. In: Journal of Investigational Allergology and Clinical Immunology. Band30, Nr.3, 18. Juni 2020, S.156–168, doi:10.18176/jiaci.0401 (jiaci.org [PDF]).
Tatsuya Isomura, Takeshi Kono, Ian Hindmarch, Norimasa Kikuchi, Aya Murakami: Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-. In: PLoS ONE. Band9, Nr.12, 12. Dezember 2014, doi:10.1371/journal.pone.0114336, PMID 25501360, PMC 4264760 (freier Volltext).
M. Nori, S. Iwata, Y. Munakata, H. Kobayashi, S. Kobayashi: Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines. In: Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. Band33, Nr.11, November 2003, S.1544–1554, doi:10.1046/j.1365-2222.2003.01701.x, PMID 14616867.
J Sastre: Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. In: Journal of Investigational Allergology and Clinical Immunology. Band30, Nr.3, 18. Juni 2020, S.156–168, doi:10.18176/jiaci.0401 (jiaci.org [PDF]).
A. del Cuvillo, J. Mullol, J. Bartra, I. Dávila, I. Jáuregui: Comparative pharmacology of the H1 antihistamines. In: Journal of Investigational Allergology & Clinical Immunology. 16 Suppl 1, 2006, S.3–12, PMID 17357372 (jiaci.org [PDF]).
nih.gov
ncbi.nlm.nih.gov
Manabu Ohyama, Atsushi Shimizu, Kyoko Tanaka, Masayuki Amagai: Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. In: Journal of Dermatological Science. Band58, Nr.2, Mai 2010, S.154–157, doi:10.1016/j.jdermsci.2010.03.009, PMID 20388588.
Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak, Martin Storr, Jakub Fichna: Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. In: Journal of Neurogastroenterology and Motility. Band23, Nr.3, 30. Juli 2017, S.341–348, doi:10.5056/jnm16203, PMID 28551943, PMC 5503283 (freier Volltext).
Anne-Marie Ellegaard, Christian Dehlendorff, Anna C. Vind, Atul Anand, Luise Cederkvist: Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. In: EBioMedicine. Band9, Juli 2016, S.130–139, doi:10.1016/j.ebiom.2016.06.013, PMID 27333030, PMC 4972561 (freier Volltext).
Tatsuya Isomura, Takeshi Kono, Ian Hindmarch, Norimasa Kikuchi, Aya Murakami: Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-. In: PLoS ONE. Band9, Nr.12, 12. Dezember 2014, doi:10.1371/journal.pone.0114336, PMID 25501360, PMC 4264760 (freier Volltext).
A. del Cuvillo, J. Mullol, J. Bartra, I. Dávila, I. Jáuregui: Comparative pharmacology of the H1 antihistamines. In: Journal of Investigational Allergology & Clinical Immunology. 16 Suppl 1, 2006, S.3–12, PMID 17357372 (jiaci.org [PDF]).
M. Nori, S. Iwata, Y. Munakata, H. Kobayashi, S. Kobayashi: Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines. In: Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. Band33, Nr.11, November 2003, S.1544–1554, doi:10.1046/j.1365-2222.2003.01701.x, PMID 14616867.